United States · FDA National Drug Code directory
BUPROPION HCl ER (XL)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70756-830_ee47c513-8459-4292-b727-111b0bd1dbcc
- Product NDC
- 70756-830
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- BUPROPION HCl ER
- Labeler
- Lifestar Pharma LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260501
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 450 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 16000 TABLET, EXTENDED RELEASE in 1 BOX (70756-830-16) · 70756-830-16
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70756-830-30) · 70756-830-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →